61 related articles for article (PubMed ID: 14674126)
1. [Quantity estimation of the E2/E6 HPV gene products ratio can be a prognostic marker for the stage of the cervical cancer carcinogenesis].
Łukaszuk K; Liss J; Emerich J; Wójcikowski C
Ginekol Pol; 2003 Sep; 74(9):793-8. PubMed ID: 14674126
[TBL] [Abstract][Full Text] [Related]
2. [Detection of physical status of human papillomavirus 16 in cervical cancer tissue and SiHa cell line by multiplex real-time polymerase chain reaction].
Zheng Y; Peng ZL; Lou JY; Wang H
Ai Zheng; 2006 Mar; 25(3):373-7. PubMed ID: 16536998
[TBL] [Abstract][Full Text] [Related]
3. Analysis by multiplex PCR of the physical status of human papillomavirus type 16 DNA in cervical cancers.
Yoshinouchi M; Hongo A; Nakamura K; Kodama J; Itoh S; Sakai H; Kudo T
J Clin Microbiol; 1999 Nov; 37(11):3514-7. PubMed ID: 10523544
[TBL] [Abstract][Full Text] [Related]
4. High-risk human papillomavirus infection and E6 protein expression in lesions of the uterine cervix.
Pillai MR; Lakshmi S; Sreekala S; Devi TG; Jayaprakash PG; Rajalakshmi TN; Devi CG; Nair MK; Nair MB
Pathobiology; 1998; 66(5):240-6. PubMed ID: 9732239
[TBL] [Abstract][Full Text] [Related]
5. HPV prevalence, E6 sequence variation and physical state of HPV16 isolates from patients with cervical cancer in Sichuan, China.
Qiu AD; Wu EQ; Yu XH; Jiang CL; Jin YH; Wu YG; Chen Y; Chen Y; Shan YM; Zhang GN; Fan Y; Zha X; Kong W
Gynecol Oncol; 2007 Jan; 104(1):77-85. PubMed ID: 16970982
[TBL] [Abstract][Full Text] [Related]
6. Human papillomavirus type 16 status in cervical carcinoma cell DNA assayed by multiplex PCR.
Lukaszuk K; Liss J; Wozniak I; Emerich J; Wójcikowski C
J Clin Microbiol; 2003 Feb; 41(2):608-12. PubMed ID: 12574254
[TBL] [Abstract][Full Text] [Related]
7. Quantitation of human papillomavirus 16 E6 and E7 DNA and RNA in residual material from ThinPrep Papanicolaou tests using real-time polymerase chain reaction analysis.
Wang-Johanning F; Lu DW; Wang Y; Johnson MR; Johanning GL
Cancer; 2002 Apr; 94(8):2199-210. PubMed ID: 12001118
[TBL] [Abstract][Full Text] [Related]
8. Suppression of tumorigenesis by transcription units expressing the antisense E6 and E7 messenger RNA (mRNA) for the transforming proteins of the human papilloma virus and the sense mRNA for the retinoblastoma gene in cervical carcinoma cells.
Hu G; Liu W; Hanania EG; Fu S; Wang T; Deisseroth AB
Cancer Gene Ther; 1995 Mar; 2(1):19-32. PubMed ID: 7621252
[TBL] [Abstract][Full Text] [Related]
9. Asian-american variants of human papillomavirus type 16 have extensive mutations in the E2 gene and are highly amplified in cervical carcinomas.
Casas L; Galvan SC; Ordoñez RM; Lopez N; Guido M; Berumen J
Int J Cancer; 1999 Nov; 83(4):449-55. PubMed ID: 10508478
[TBL] [Abstract][Full Text] [Related]
10. HPV-16-related proteins as the serologic markers in cervical neoplasia.
Park JS; Park DC; Kim CJ; Ahn HK; Um SJ; Park SN; Kim SJ; Namkoong SE
Gynecol Oncol; 1998 Apr; 69(1):47-55. PubMed ID: 9570998
[TBL] [Abstract][Full Text] [Related]
11. Physical status and expression of HPV genes in cervical cancers.
Park JS; Hwang ES; Park SN; Ahn HK; Um SJ; Kim CJ; Kim SJ; Namkoong SE
Gynecol Oncol; 1997 Apr; 65(1):121-9. PubMed ID: 9103401
[TBL] [Abstract][Full Text] [Related]
12. The presence of human papillomavirus-16/-18 E6, p53, and Bcl-2 protein in cervicovaginal smears from patients with invasive cervical cancer.
Pillai MR; Halabi S; McKalip A; Jayaprakash PG; Rajalekshmi TN; Nair MK; Herman B
Cancer Epidemiol Biomarkers Prev; 1996 May; 5(5):329-35. PubMed ID: 9162297
[TBL] [Abstract][Full Text] [Related]
13. Determination of human papillomavirus 16 physical status through E1/E6 and E2/E6 ratio analysis.
Tsakogiannis D; Kyriakopoulou Z; Ruether IGA; Amoutzias GD; Dimitriou TG; Diamantidou V; Kotsovassilis C; Markoulatos P
J Med Microbiol; 2014 Dec; 63(Pt 12):1716-1723. PubMed ID: 25212758
[TBL] [Abstract][Full Text] [Related]
14. [Analysis on the expression of human papillomavirus type 16 E2 and E6 oncogenes and disruption of E2 in cervical cancer].
Wang JT; Ding L; Gao ES; Cheng YY
Zhonghua Liu Xing Bing Xue Za Zhi; 2007 Oct; 28(10):968-71. PubMed ID: 18399141
[TBL] [Abstract][Full Text] [Related]
15. Decreased expression of human papillomavirus E2 protein and transforming growth factor-beta1 in human cervical neoplasia as an early marker in carcinogenesis.
Torng PL; Chan WY; Lin CT; Huang SC
J Surg Oncol; 2003 Sep; 84(1):17-23. PubMed ID: 12949986
[TBL] [Abstract][Full Text] [Related]
16. Human papillomavirus DNA and virus-encoded antigens in cervical carcinoma.
Padmanathan A; Yadav M; Gregory AR; Kumar S; Norhanum AW
Med J Malaysia; 1997 Jun; 52(2):108-16. PubMed ID: 10968067
[TBL] [Abstract][Full Text] [Related]
17. Impact of viral E2-gene status on outcome after radiotherapy for patients with human papillomavirus 16-positive cancer of the uterine cervix.
Lindel K; de Villiers EM; Burri P; Studer U; Altermatt HJ; Greiner RH; Gruber G
Int J Radiat Oncol Biol Phys; 2006 Jul; 65(3):760-5. PubMed ID: 16682151
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of HPV-18 and variants of E6 gene isolated from cervical cancer patients in Taiwan.
Chang CH; Chen TH; Hsu RC; Chou PH; Yang JJ; Hwang GY
J Clin Virol; 2005 Jan; 32(1):33-7. PubMed ID: 15572004
[TBL] [Abstract][Full Text] [Related]
19. C/EBPbeta activity and HPV-16 E6/E7 mRNA expression are not altered by imiquimod (ALDARA) in human cervical cancer cells in vitro.
Belcastro M; Miller MR; Flynn DC; Soisson AP
Gynecol Oncol; 2004 Feb; 92(2):660-8. PubMed ID: 14766263
[TBL] [Abstract][Full Text] [Related]
20. Human papillomavirus type 16 variant analysis of E6, E7, and L1 genes and long control region in biopsy samples from cervical cancer patients in north India.
Pande S; Jain N; Prusty BK; Bhambhani S; Gupta S; Sharma R; Batra S; Das BC
J Clin Microbiol; 2008 Mar; 46(3):1060-6. PubMed ID: 18199779
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
